LSI vs XFOR
LSI (LSI) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
LSI does not have a complete income-statement cache yet.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
XFOR currently screens at market cap $382.0M.
Not investment advice. Open the LSI and XFOR stock pages for the full models.
Not investment advice.